Publications (38) View all
-
Article: The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms.
Antonino Cannas, Giuseppe Borghero, Gian Luca Floris, Paolo Solla, Adriano Chiò, Bryan J Traynor, Andrea Calvo, Gabriella Restagno, Elisa Majounie, Emanuela Costantino, [......], Paolo Tacconi, Marcello Mario Mascia, Antonella Muroni, Maria Rita Murru, Stefania Tranquilli, Daniela Corongiu, Marcella Rolesu, Stefania Cuccu, Francesco Marrosu, Maria Giovanna Marrosu[show abstract] [hide abstract]
ABSTRACT: Based on our previous finding of the p.A382T founder mutation in ALS patients with concomitant parkinsonism in the Sardinian population, we hypothesized that the same variant may underlie Parkinson's disease (PD) and/or other forms of degenerative parkinsonism on this Mediterranean island. We screened a cohort of 611 patients with PD (544 cases) and other forms of degenerative parkinsonism (67 cases) and 604 unrelated controls for the c.1144G > A (p.A382T) missense mutation of the TARDBP gene. The p.A382T mutation was identified in nine patients with parkinsonism. Of these, five (0.9 % of PD patients) presented a typical PD (two with familiar forms), while four patients (6.0 % of all other forms of parkinsonism) presented a peculiar clinical presentation quite different from classical atypical parkinsonism with an overlap of extrapyramidal-pyramidal-cognitive clinical signs. The mutation was found in eight Sardinian controls (1.3 %) consistent with a founder mutation in the island population. Our findings suggest that the clinical presentation of the p.A382T TARDBP gene mutation may include forms of parkinsonism in which the extrapyramidal signs are the crucial core of the disease at onset. These forms can present PSP or CBD-like clinical signs, with bulbar and/or extrabulbar pyramidal signs and cognitive impairment. No evidence of association has been found between TARDBP gene mutation and typical PD.Neurogenetics 04/2013; · 3.35 Impact Factor -
Article: Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels.
Fernando Bartolome, Hsiu-Chuan Wu, Victoria S Burchell, Elisavet Preza, Selina Wray, Colin J Mahoney, Nick C Fox, Andrea Calvo, Antonio Canosa, Cristina Moglia, Jessica Mandrioli, Adriano Chiò, Richard W Orrell, Henry Houlden, John Hardy, Andrey Y Abramov, Helene Plun-Favreau[show abstract] [hide abstract]
ABSTRACT: Valosin-containing protein (VCP) is a highly expressed member of the type II AAA+ ATPase family. VCP mutations are the cause of inclusion body myopathy, Paget's disease of the bone, and frontotemporal dementia (IBMPFD) and they account for 1%-2% of familial amyotrophic lateral sclerosis (ALS). Using fibroblasts from patients carrying three independent pathogenic mutations in the VCP gene, we show that VCP deficiency causes profound mitochondrial uncoupling leading to decreased mitochondrial membrane potential and increased mitochondrial oxygen consumption. This mitochondrial uncoupling results in a significant reduction of cellular ATP production. Decreased ATP levels in VCP-deficient cells lower their energy capacity, making them more vulnerable to high energy-demanding processes such as ischemia. Our findings propose a mechanism by which pathogenic VCP mutations lead to cell death.Neuron 03/2013; · 14.74 Impact Factor -
Article: Extensive genetics of ALS: A population-based study in Italy.
Adriano Chiò, Andrea Calvo, Letizia Mazzini, Roberto Cantello, Gabriele Mora, Cristina Moglia, Lucia Corrado, Sandra D'Alfonso, Elisa Majounie, Alan Renton, Fabrizio Pisano, Irene Ossola, Maura Brunetti, Bryan J Traynor, Gabriella Restagno[show abstract] [hide abstract]
ABSTRACT: OBJECTIVE: To assess the frequency and clinical characteristics of patients with mutations of major amyotrophic lateral sclerosis (ALS) genes in a prospectively ascertained, population-based epidemiologic series of cases. METHODS: The study population includes all ALS cases diagnosed in Piemonte, Italy, from January 2007 to June 2011. Mutations of SOD1, TARDBP, ANG, FUS, OPTN, and C9ORF72 have been assessed. RESULTS: Out of the 475 patients included in the study, 51 (10.7%) carried a mutation of an ALS-related gene (C9ORF72, 32; SOD1, 10; TARDBP, 7; FUS, 1; OPTN, 1; ANG, none). A positive family history for ALS or frontotemporal dementia (FTD) was found in 46 (9.7%) patients. Thirty-one (67.4%) of the 46 familial cases and 20 (4.7%) of the 429 sporadic cases had a genetic mutation. According to logistic regression modeling, besides a positive family history for ALS or FTD, the chance to carry a genetic mutation was related to the presence of comorbid FTD (odds ratio 3.5; p = 0.001), and age at onset ≤54 years (odds ratio 1.79; p = 0.012). CONCLUSIONS: We have found that ∼11% of patients with ALS carry a genetic mutation, with C9ORF72 being the commonest genetic alteration. Comorbid FTD or a young age at onset are strong indicators of a possible genetic origin of the disease.Neurology 10/2012; · 8.31 Impact Factor -
Article: Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene.
Andrea Calvo, Cristina Moglia, Antonio Canosa, Angelina Cistaro, Consuelo Valentini, Giovanna Carrara, Enzo Soldano, Antonio Ilardi, Enrica Bersano, Davide Bertuzzo, Maura Brunetti, Irene Ossola, Gabriella Restagno, Adriano ChiòJournal of Neurology 08/2012; · 3.47 Impact Factor -
Article: UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study.
Adriano Chiò, Gabriele Mora, Gabriella Restagno, Maura Brunetti, Irene Ossola, Marco Barberis, Luigi Ferrucci, Antonio Canosa, Umberto Manera, Cristina Moglia, Giuseppe Fuda, Bryan J Traynor, Andrea Calvo[show abstract] [hide abstract]
ABSTRACT: The common variant rs12608932, located within an intron of UNC13A gene on chromosome 19p13.3, has been suggested to influence susceptibility to amyotrophic lateral sclerosis (ALS), as well as survival, in patients of north European descent. To examine this possibility further, we evaluated the association of rs12608932 with susceptibility and survival in a population-based cohort of 500 Italian ALS patients and 1457 Italian control samples. Although rs12608932 was not associated with ALS susceptibility in our series (p = 0.124), it was significantly associated with survival under the recessive model (median survival for AA/AC genotypes = 3.5 years [interquartile range, 2.2-6.4]; CC = 2.5 years [interquartile range, 1.6-4.2]; p = 0.017). Furthermore, rs12608932 genotype remained an independent prognostic factor in Cox multivariable analysis adjusting for other factors known to influence survival (p = 0.023). Overall, minor allele carrier status of rs12608932 was strongly associated with an approximate 1-year reduction of survival in ALS patients, making it a significant determinant of phenotype variation. The identification of UNC13A as a modifier of prognosis among sporadic ALS patients potentially provides a new therapeutic target aimed at slowing disease progression.Neurobiology of aging 08/2012; · 5.94 Impact Factor